Learn more about Wellcome Trust’s call to support high-impact, locally led randomised controlled trials that optimise licensed pharmaceutical interventions for infectious diseases. Up to £8 million per award is available for transdisciplinary teams based in Africa, South Asia or South-East Asia.
About the Call for Applications
Wellcome is looking for projects with a focus on optimising an existing vaccine or therapeutic targeting one of the following disease areas:
- mycobacterial infections: tuberculosis, leprosy or infections with non-tuberculous mycobacteria
- bacterial infections: sexually transmitted infections, lower respiratory tract infections or bloodstream infections
- invasive fungal infections
- dengue, leishmaniasis or schistosomiasis
The clinical trial should generate evidence that can inform changes to policy and practice, ultimately improving prevention and treatment of infectious diseases in low- and middle-income countries. The deadline to submit your application is Tuesday 2 June 2026.
Support for early-stage ideas
If you have an innovative concept but need time to build your team, strengthen your protocol or generate pilot data, you can apply for our Infectious Disease Clinical Trial Development Award, delivered in partnership with the Foreign, Commonwealth and Development Office (FCDO). The deadline to submit your application for a development award is Tuesday 19 May 2026.
Learn more about the funding opportunity here.
